JLGRX
Price
$95.64
Change
+$0.05 (+0.05%)
Updated
Dec 3 closing price
Net Assets
124.57B
RGACX
Price
$86.23
Change
+$0.52 (+0.61%)
Updated
Dec 3 closing price
Net Assets
338.91B
Interact to see
Advertisement

JLGRX vs RGACX

Header iconJLGRX vs RGACX Comparison
Open Charts JLGRX vs RGACXBanner chart's image
JPMorgan Large Cap Growth R5
Price$95.64
Change+$0.05 (+0.05%)
VolumeN/A
Net Assets124.57B
American Funds Growth Fund of Amer R3
Price$86.23
Change+$0.52 (+0.61%)
VolumeN/A
Net Assets338.91B
JLGRX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
JLGRX vs. RGACX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGRX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 339B vs. JLGRX (125B). JLGRX pays higher dividends than RGACX: JLGRX (0.10) vs RGACX (0.07). JLGRX was incepted earlier than RGACX: JLGRX (17 years) vs RGACX (24 years). RGACX (0.94) is less costly to investors than JLGRX (0.60). JLGRX is a more actively managed with annual turnover of: 52.00 vs. RGACX (25.00). JLGRX has a lower initial minimum investment than RGACX: JLGRX (0) vs RGACX (250). JLGRX annual gain was more profitable for investors over the last year : 12.77 vs. RGACX (6.46). JLGRX return over 5 years is better than : 51.88 vs. RGACX (29.83).
JLGRXRGACXJLGRX / RGACX
Total Expense Ratio0.540.9457%
Annual Report Gross Expense Ratio0.600.9464%
Fund Existence17 years24 years-
Gain YTD15.01118.55881%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets125B339B37%
Annual Yield % from dividends0.100.07144%
Returns for 1 year12.776.46198%
Returns for 3 years86.3760.09144%
Returns for 5 years51.8829.83174%
Returns for 10 years149.0889.90166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEPH5.430.20
+3.80%
Nephros
WTFCN26.34-0.03
-0.11%
Wintrust Financial Corp
HSIC71.65-1.46
-2.00%
Henry Schein
PTLO4.94-0.14
-2.76%
Portillo's
NRIX16.35-0.56
-3.31%
Nurix Therapeutics